Literature DB >> 8546689

Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.

T Adachi1, H Yamada, Y Yamada, N Morihara, N Yamazaki, T Murakami, A Futenma, K Kato, K Hirano.   

Abstract

Extracellular-superoxide dismutase (EC-SOD) levels in sera divide into two discontinuous groups: a low-level group below 400 ng/ml and a high-level group above 400 ng/ml [Adachi, Nakamura, Yamada, Futenma, Kato and Hirano (1994) Clin. Chim. Acta 229, 123-131]. Molecular genetic studies have shown that the donors in the high-level group have a single base substitution generating the exchange of glycine for arginine-213 (R213G) in the heparin-binding domain of EC-SOD [Sandström, Nilsson, Karlsson and Marklund (1994) J. Biol. Chem. 269, 19163-19166; Yamada, Yamada, Adachi, Goto, Ogasawara, Futenma, Kitano, Hirano and Kato (1995) Jpn. J. Hum. Genet. 40, 177-184]. The serum EC-SOD level in homozygote subjects was significantly higher than that in heterozygotes and in normal subjects. Serum EC-SOD from heterozygotes and homozygotes had equally decreased affinity for heparin, as judged by heparin-HPLC, as compared with that from normal donors. This result suggests that the serum EC-SOD in heterozygotes was mainly composed of the mutant form which has reduced heparin affinity. On the other hand, fibroblast cells derived from heterozygote subjects generated mRNA of both normal and mutant EC-SOD (m-EC-SOD), and expressed the corresponding proteins. EC-SOD is a tetrameric enzyme, and in heterozygote donors would be heterogeneous with regard to the constitution of normal and mutant subunits. The enzyme form consisting of only mutant subunits, the form with the weakest heparin affinity, can be preferentially driven out to the plasma phase, because EC-SOD in the vasculature exists in equilibrium between plasma and the endothelial cell surface. The binding of m-EC-SOD to bovine aortic endothelial cells was about 50-fold less than that of normal EC-SOD. This result suggests that the binding of m-EC-SOD to vascular endothelial cells is much decreased in vivo, which causes a high level of serum EC-SOD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546689      PMCID: PMC1216888          DOI: 10.1042/bj3130235

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Interactions between human extracellular superoxide dismutase C and sulfated polysaccharides.

Authors:  T Adachi; S L Marklund
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

2.  The heparin binding site of human extracellular-superoxide dismutase.

Authors:  T Adachi; T Kodera; H Ohta; K Hayashi; K Hirano
Journal:  Arch Biochem Biophys       Date:  1992-08-15       Impact factor: 4.013

3.  Non-enzymic glycation of human extracellular superoxide dismutase.

Authors:  T Adachi; H Ohta; K Hirano; K Hayashi; S L Marklund
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

4.  Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody.

Authors:  T Adachi; H Ohta; H Yamada; A Futenma; K Kato; K Hirano
Journal:  Clin Chim Acta       Date:  1992-11-30       Impact factor: 3.786

5.  Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase.

Authors:  K Karlsson; A Edlund; J Sandström; S L Marklund
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

6.  The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity.

Authors:  J Sandström; L Carlsson; S L Marklund; T Edlund
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

7.  Molecular analysis of five independent Japanese mutant genes responsible for hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency.

Authors:  Y Yamada; H Goto; K Suzumori; R Adachi; N Ogasawara
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

8.  Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues.

Authors:  J Sandström; K Karlsson; T Edlund; S L Marklund
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

9.  The nature of heterogeneous components of extracellular-superoxide dismutase purified from human umbilical cords.

Authors:  H Ohta; T Adachi; K Hirano
Journal:  Free Radic Biol Med       Date:  1993-08       Impact factor: 7.376

10.  Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells.

Authors:  K Karlsson; S L Marklund
Journal:  Lab Invest       Date:  1989-05       Impact factor: 5.662

View more
  15 in total

Review 1.  Diabetes, oxidative stress and physical exercise.

Authors:  Mustafa Atalay; David E Laaksonen
Journal:  J Sports Sci Med       Date:  2002-03-04       Impact factor: 2.988

Review 2.  Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases.

Authors:  Nguyen Hoai Nguyen; Gia-Buu Tran; Cuong Thach Nguyen
Journal:  J Mol Med (Berl)       Date:  2019-11-13       Impact factor: 4.599

3.  Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Joann M Taylor; Richard K P Benninger; Richard D Johnson; Leah R Villegas; Kurt R Stenmark; David G Harrison; Susan M Majka; David Irwin; Kathryn N Farrow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-17       Impact factor: 5.464

4.  Effects of a common human gene variant of extracellular superoxide dismutase on endothelial function after endotoxin in mice.

Authors:  Donald D Lund; Yi Chu; Robert M Brooks; Frank M Faraci; Donald D Heistad
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

Review 5.  Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD.

Authors:  Zhenyu Qin; Krzysztof J Reszka; Tohru Fukai; Neal L Weintraub
Journal:  Transl Res       Date:  2007-11-08       Impact factor: 7.012

6.  Extracellular superoxide dismutase regulates cardiac function and fibrosis.

Authors:  Corrine R Kliment; Hagir B Suliman; Jacob M Tobolewski; Crystal M Reynolds; Brian J Day; Xiaodong Zhu; Charles F McTiernan; Kenneth R McGaffin; Claude A Piantadosi; Tim D Oury
Journal:  J Mol Cell Cardiol       Date:  2009-08-18       Impact factor: 5.000

Review 7.  Regulation of superoxide dismutase genes: implications in disease.

Authors:  Lu Miao; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2009-05-25       Impact factor: 7.376

8.  The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities.

Authors:  Steen V Petersen; Dorte Aa Olsen; John M Kenney; Tim D Oury; Zuzana Valnickova; Ida B Thøgersen; James D Crapo; Jan J Enghild
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

9.  Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus.

Authors:  D A Chistyakov; K V Savost'anov; E V Zotova; V V Nosikov
Journal:  BMC Med Genet       Date:  2001-03-28       Impact factor: 2.103

10.  Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.

Authors:  Kamel Mohammedi; Naïma Bellili-Muñoz; Stefan L Marklund; Fathi Driss; Hervé Le Nagard; Thiago A Patente; Frédéric Fumeron; Ronan Roussel; Samy Hadjadj; Michel Marre; Gilberto Velho
Journal:  Cardiovasc Diabetol       Date:  2015-01-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.